Elevance Health, Inc. ELV
NYSE
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 3.25% | 6.36% | 10.30% | 14.10% | 11.93% |
| Total Other Revenue | 5.36% | 5.82% | 5.32% | 5.56% | 12.09% |
| Total Revenue | 3.60% | 6.27% | 9.44% | 12.62% | 11.96% |
| Cost of Revenue | 3.36% | 7.49% | 12.24% | 16.19% | 14.56% |
| Gross Profit | 4.27% | 2.92% | 2.16% | 3.37% | 5.24% |
| SG&A Expenses | 7.73% | 8.49% | 7.72% | 8.19% | 12.83% |
| Depreciation & Amortization | -23.60% | -9.27% | -5.49% | 8.28% | 4.38% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 4.25% | 7.66% | 11.12% | 14.31% | 14.13% |
| Operating Income | -10.11% | -20.43% | -20.23% | -15.88% | -20.21% |
| Income Before Tax | -11.98% | -17.06% | -19.90% | -15.11% | -14.44% |
| Income Tax Expenses | -27.08% | -46.77% | -47.20% | -45.73% | -17.64% |
| Earnings from Continuing Operations | -7.69% | -7.52% | -11.33% | -5.19% | -13.48% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 620.00% | 45.45% | -45.45% | -88.89% | -82.76% |
| Net Income | -7.12% | -7.41% | -11.39% | -5.32% | -13.79% |
| EBIT | -10.11% | -20.43% | -20.23% | -15.88% | -20.21% |
| EBITDA | -9.08% | -17.35% | -16.83% | -12.55% | -16.95% |
| EPS Basic | -4.00% | -4.30% | -8.47% | -2.23% | -11.07% |
| Normalized Basic EPS | -9.09% | -22.26% | -22.53% | -18.17% | -23.15% |
| EPS Diluted | -4.14% | -4.27% | -8.28% | -1.92% | -10.83% |
| Normalized Diluted EPS | -9.19% | -22.22% | -22.40% | -17.98% | -23.00% |
| Average Basic Shares Outstanding | -3.40% | -3.58% | -3.42% | -3.36% | -2.85% |
| Average Diluted Shares Outstanding | -3.32% | -3.64% | -3.58% | -3.57% | -3.06% |
| Dividend Per Share | 1.63% | 2.69% | 3.79% | 4.91% | 6.12% |
| Payout Ratio | 0.06% | 0.07% | 0.13% | 0.07% | 0.19% |